Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Cold-FX (CVT-E002) in the Prevention of Upper Respiratory Tract Infections in Healthy Adult Employees in Continuing Care Facilities

NCT00259831 is registered in ClinicalTrials.gov with CV Technologies as lead sponsor.

NCT NCT00259831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00259831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Cold-FX (CVT-E002) in the Prevention of Upper Respiratory Tract Infections in Healthy Adult Employees in Continuing Care Facilities
Lead sponsor
CV Technologies
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2005
Completion date
August 31, 2006
Enrollment
500
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

upper respiratory infection